Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina: Ethnic differences detected in an international comparative study.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 09 11 2018
revised: 27 12 2018
accepted: 18 02 2019
pubmed: 2 3 2019
medline: 15 5 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

Possible ethnic differences in clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina (VSA) remain to be elucidated. The Japanese Coronary Spasm Association (JCSA) conducted an international, prospective, and multicenter registry study for VSA patients. A total of 1457 VSA patients (Japanese/Caucasians, 1339/118) were enrolled based on the same diagnostic criteria. Compared with Caucasian patients, Japanese patients were characterized by higher proportions of males (68 vs. 51%) and smoking history (60 vs. 49%). Japanese patients more often had angina especially during the night and early morning hours, compared with Caucasians. Ninety-five percent of Japanese and 84% of Caucasian patients underwent pharmacological provocation test. Importantly, no significant differences in the patterns of coronary spasm were apparent, with diffuse spasm most frequently noted in both ethnicities. The prescription rate of calcium-channel blockers was higher in Japanese (96 vs. 86%), whereas the uses of nitrates (46 vs. 59%), statins (43 vs. 65%), renin-angiotensin-system inhibitors (27 vs. 51%), and β-blockers (10 vs. 24%) were more common in Caucasian patients. Survival rate free from major adverse cardiac events (MACE) was slightly but significantly higher in Japanese than in Caucasians (86.7 vs. 76.6% at 5 years, P < 0.001). Notably, multivariable analysis revealed that the JCSA risk score correlated with MACE rates not only in Japanese but also in Caucasian patients. These results indicate that there are ethnic differences in clinical profiles and long-term prognosis of contemporary VSA patients.

Sections du résumé

BACKGROUND
Possible ethnic differences in clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina (VSA) remain to be elucidated.
METHODS AND RESULTS
The Japanese Coronary Spasm Association (JCSA) conducted an international, prospective, and multicenter registry study for VSA patients. A total of 1457 VSA patients (Japanese/Caucasians, 1339/118) were enrolled based on the same diagnostic criteria. Compared with Caucasian patients, Japanese patients were characterized by higher proportions of males (68 vs. 51%) and smoking history (60 vs. 49%). Japanese patients more often had angina especially during the night and early morning hours, compared with Caucasians. Ninety-five percent of Japanese and 84% of Caucasian patients underwent pharmacological provocation test. Importantly, no significant differences in the patterns of coronary spasm were apparent, with diffuse spasm most frequently noted in both ethnicities. The prescription rate of calcium-channel blockers was higher in Japanese (96 vs. 86%), whereas the uses of nitrates (46 vs. 59%), statins (43 vs. 65%), renin-angiotensin-system inhibitors (27 vs. 51%), and β-blockers (10 vs. 24%) were more common in Caucasian patients. Survival rate free from major adverse cardiac events (MACE) was slightly but significantly higher in Japanese than in Caucasians (86.7 vs. 76.6% at 5 years, P < 0.001). Notably, multivariable analysis revealed that the JCSA risk score correlated with MACE rates not only in Japanese but also in Caucasian patients.
CONCLUSION
These results indicate that there are ethnic differences in clinical profiles and long-term prognosis of contemporary VSA patients.

Identifiants

pubmed: 30819587
pii: S0167-5273(18)36517-3
doi: 10.1016/j.ijcard.2019.02.038
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-18

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Koichi Sato (K)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Jun Takahashi (J)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Yuji Odaka (Y)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Akira Suda (A)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Shozo Sueda (S)

Ehime Prefectural Niihama Hospital, Niihama, Japan.

Hiroki Teragawa (H)

JR Hiroshima Hospital, Hiroshima, Japan.

Katsuhisa Ishii (K)

Kansai Electric Power Hospital, Osaka, Japan.

Takahiko Kiyooka (T)

Tokai University Oiso Hospital, Oiso, Japan.

Atsushi Hirayama (A)

Osaka Police Hospital, Osaka, Japan.

Tetsuya Sumiyoshi (T)

Sakakibara Heart Institute, Tokyo, Japan.

Yasuhiko Tanabe (Y)

Niigata Prefectural Shibata Hospital, Shibata, Japan.

Kazuo Kimura (K)

Yokohama City University Medical Center, Yokohama, Japan.

Koichi Kaikita (K)

Kumamoto University Hospital, Kumamoto, Japan.

Peter Ong (P)

Robert-Bosch-Krankenhaus, Stuttgart, Germany.

Udo Sechtem (U)

Robert-Bosch-Krankenhaus, Stuttgart, Germany.

Paolo G Camici (PG)

Vita Salute University and San Raffaele Hospital, Milan, Italy.

Juan Carlos Kaski (JC)

St George's University of London, London, UK.

Filippo Crea (F)

Catholic University of the Sacred Heart, Roma, Italy.

John F Beltrame (JF)

University of Adelaide, Adelaide, Australia.

Hiroaki Shimokawa (H)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: shimo@cardio.med.tohoku.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH